Literature DB >> 1267046

Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.

J J Schildkraut, J M Herzog, P J Orsulak, S E Edelman, H M Shein, S H Frazier.   

Abstract

Platelet monoamine oxidase (MAO) activity was significantly lower than control values in a subgroup of 16 schizophrenic patients (most of whom were paranoid) characterized by the presence of auditory hallucinations and delusions. Platelet MAO activity was not reduced in 16 other schizophrenic patients without auditory hallucinations. This finding suggests that reduced platelet MAO activity is not found in all schizophrenic patients but tends to occur in a clinically identifiable subgroup.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1267046     DOI: 10.1176/ajp.133.4.438

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

2.  Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.

Authors:  P Propping; W Friedl
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

3.  Clinical variables and platelet mao in schizophrenia.

Authors:  I Sharma; A Kumar; J P Chansouria; S L Varma
Journal:  Indian J Psychiatry       Date:  1991-10       Impact factor: 1.759

4.  Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.

Authors:  J J Mann; R D Kaplan; A Georgotas; E Friedman; M Branchey; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

6.  Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.

Authors:  L Demisch; H von der Mühlen; H J Bochnik; N Seiler
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

Review 7.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.